FindTrial
Sign In

Study of occurrence of low magnesium and its effect on clinical outcome in severly ill patients.

Study of prevalence of hypomagnesemia and its effect on clinical outcome in Critically ill patients. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/062093
Enrollment
144
Registered
2024-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified Health Condition 2: E889- Metabolic disorder, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Sponsors

Dr TMA Pai Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients who are critically ill Age above 18 years Admitted to ICU or HDU APACHE II SCORE 18 or more

Exclusion criteria

Exclusion criteria: Patients who are given magnesium infusion during the current or within last 24-48 hrs Patients who received blood products within 24-48hrs Patients who had burns injury within last 4 weeks. Patients with acute or chronic renal failure on dialysis.

Design outcomes

Primary

MeasureTime frame
The result will be used to determine the prevalence of hypomagnesemia in critically ill patients admitted to ICU & HDU and to determine outcome like need for mechanical ventilation,early extubation,hospital stay,mortality. Critically ill patients identified through APACHE II scoreTimepoint: 12 months & 18 months—

Secondary

MeasureTime frame
To determine association of hypomagnesemia with other electrolytes(calcium and pottasium)Timepoint: 12 & 18 months—

Countries

India

Contacts

Public ContactChaithanya P P

Dr TMA Pai Hospital

shashikiran.u@manipal.edu9008418171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026